Premium
Should ovarian cryopreservation be offered to girls with cancer
Author(s) -
Weintraub Michael,
Gross Eitan,
Kadari Avishag,
Ravitsky Vardit,
Safran Anat,
Laufer Neri,
Revel Ariel
Publication year - 2007
Publication title -
pediatric blood and cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.116
H-Index - 105
eISSN - 1545-5017
pISSN - 1545-5009
DOI - 10.1002/pbc.20946
Subject(s) - medicine , fertility preservation , infertility , childhood cancer , cryopreservation , fertility , ovarian tissue cryopreservation , ovarian cancer , cancer , gynecology , oncology , intensive care medicine , pregnancy , population , environmental health , biology , embryo , genetics , microbiology and biotechnology
Current therapy of childhood cancer makes long‐term survival a realistic outcome for most patients. However, some treatment regimens entail a significant risk of infertility. No established method for preservation of female fertility is currently available. Ovarian cryopreservation is an experimental technology that is being offered with increasing frequency to women undergoing cancer therapy. It has not yet been reported in children and adolescent girls. The aim of this review is to stimulate discussion on the possibility of performing ovarian cryopreservation in pre‐menarcheal girls in advance of therapies that may induce ovarian failure. We present a multi‐disciplinary discussion of the risks and benefits associated with the procedure and propose guidelines for its implementation. We propose that all girls about to receive treatment that has a high risk for infertility be offered consultation about the possibility of ovarian cryopreservation. Pediatr Blood Cancer 2007;48:4–9. © 2006 Wiley‐Liss, Inc.